| 000 | 00856nam a2200289Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20221007125506.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 221006b |||||||| |||| 00| 0 eng d | ||
| 020 | _a0126437327 (hbd) | ||
| 024 | _a1732 | ||
| 037 | _cTextual | ||
| 040 |
_aCDL _cCDL _beng |
||
| 041 |
_2eng _aeng |
||
| 082 | _aLZ3:(E), N2 Carc | ||
| 100 | _aSilverman Richard B. | ||
| 245 | 0 | _aOrganic chemistry of drug design and drug action | |
| 250 | _aEd. 2 | ||
| 260 |
_aAmsterdam _bElsevier Academic Press _c1998 |
||
| 300 |
_axix, 617p. _ccm. |
||
| 500 | _aIncludes bliographical references; Appendix 559-592p; Index 593-617p | ||
| 650 | _a Drug design | ||
| 650 | _aOrganic Chemistry | ||
| 942 |
_hLZ3:(E), N2 Carc _cTEXL _2CC |
||
| 999 |
_c1215386 _d1215386 |
||